Profile
Tom Bu worked as an Independent Director at Cineverse Corp.
from 2020 to 2021.
Prior to that, he was the Finance Director at Bison Finance Group Ltd.
He worked as an Audit Manager at KPMG Huazhen LLP from 2013 to 2017.
He was also the Chief Financial & Accounting Officer at Bison Capital Acquisition Corp.
and the Chief Financial Officer at Xynomic Pharmaceuticals Holdings, Inc. from 2017 to 2019.
Mr. Bu graduated from Ocean University of China with a graduate degree in 2010 and from Shandong Economic University with an undergraduate degree in 2007.
Former positions of Tom Bu
| Companies | Position | End |
|---|---|---|
| CINEVERSE CORP. | Director/Board Member | 2021-08-05 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director of Finance/CFO | 2019-05-31 |
KPMG Huazhen LLP
 KPMG Huazhen LLP Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG Huazhen LLP is a Chinese company that provides accounting services. The company is based in Beijing, China. | Corporate Officer/Principal | 2017-04-30 |
| BISON FINANCE GROUP LIMITED | Director of Finance/CFO | - |
Bison Capital Acquisition Corp.
 Bison Capital Acquisition Corp. Financial ConglomeratesFinance Bison Capital Acquisition Corp. is currently a blank check company, which primarily engages in the acquisition, and engagement in share exchange, share reconstruction and amalgamation with, contractual control arrangement with, purchasing all or substantially all of the assets of an entity. It also plans on engaging in any other similar business combination with one or more entities. The company is headquartered in Beijing, China. | Director of Finance/CFO | - |
Training of Tom Bu
| Shandong Economic University | Undergraduate Degree |
| Ocean University of China | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CINEVERSE CORP. | Consumer Services |
| BISON FINANCE GROUP LIMITED | Finance |
| Private companies | 3 |
|---|---|
Bison Capital Acquisition Corp.
Bison Capital Acquisition Corp. Financial ConglomeratesFinance Bison Capital Acquisition Corp. is currently a blank check company, which primarily engages in the acquisition, and engagement in share exchange, share reconstruction and amalgamation with, contractual control arrangement with, purchasing all or substantially all of the assets of an entity. It also plans on engaging in any other similar business combination with one or more entities. The company is headquartered in Beijing, China. | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
KPMG Huazhen LLP
KPMG Huazhen LLP Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG Huazhen LLP is a Chinese company that provides accounting services. The company is based in Beijing, China. | Commercial Services |
- Stock Market
- Insiders
- Tom Bu
